Alzheimer's disease (AD) is marked by progressive memory loss, cognitive decline, and behavioral changes that profoundly impact quality of life. Understanding these complex symptoms requires preclinical models that accurately replicate human pathology and enable rigorous evaluation of potential therapies. At Ace Therapeutics, we specialize in preclinical behavioral and cognitive testing using validated AD animal models, providing researchers with the tools to assess drug efficacy, unravel disease mechanisms, and bridge the gap between lab discoveries and clinical success.
Behavioral and cognitive assessments are critical for capturing the multifaceted nature of AD. While biomarkers and molecular analyses reveal pathological hallmarks like amyloid-beta (Aβ) plaques and tau tangles, behavioral testing directly measures how these pathologies impair memory, learning, and daily functioning.
Fig. 1. Recently introduced behavioral tests. (Hånell, A., et al., 2014)
Our services focus on models that mirror human cognitive deficits, ensuring translational relevance for drug development.
By integrating advanced behavioral paradigms with genetic and pharmacological interventions, we help researchers answer key questions
Spatial memory deficits are a hallmark of AD. We employ gold-standard assays to evaluate this domain
Memory loss in AD extends beyond spatial navigation. Our tests include
AD disrupts executive function. We assess these domains using
Neuropsychiatric symptoms often accompany cognitive decline. Our protocols include
We leverage cutting-edge technology to enhance accuracy and throughput
Ace Therapeutics combines cutting-edge models, scalable platforms, and deep disease expertise to illuminate the path from bench to preclinical success. Contact us today to build a tailored testing strategy that aligns with your scientific goals.
How long does a typical Morris water maze study take?
Most studies require 5–7 training days followed by probe trials, with data analysis completed within 2 weeks.
Can you test vascular dementia models?
Yes. We offer behavioral testing in models combining cerebral hypoperfusion with AD pathology.
Do you validate cognitive assays in aged wild-type rodents?
Absolutely. Aged wild-type animals serve as controls for age-related cognitive decline studies.
How do you minimize stress in behavioral testing?
We use habituation protocols, low-stress mazes (e.g., Barnes maze), and home cage monitoring systems.
Reference
Our products and services are for research use only and can not be used for diagnostic or other purposes.
Make Order
Experimental Scheme
Implementation
Conclusion
Ace Therapeutics is a specialized team of scientists and technical professionals committed to working closely with clients worldwide. We offer comprehensive preclinical testing solutions to support the development of novel therapies and medications across a range of disease areas.